Despite the most recent sophisticated investigations, the nature of Hodgkin's disease (HD)
continues to be poorly understood. Basic questions concerning numerous aspects of the …

During the past decade, there have been many advances in our understanding of Hodgkin's
disease. Among the most important is the discovery that the Reed-Sternberg cell is a …

Hodgkin's disease is considered a distinct clinical entity, but it exhibits a wide range of
histologic and cytologic features. Four histologic subtypes and numerous variant subtypes …

The clinical, morphological and immunological findings in nine cases of relapsing
lymphocyte predominance Hodgkin's disease (LPHD) are examined. Six patients had initial …

There is wide consensus that lymphocyte predominance Hodgkin's disease (LPHD)
represents a distinct clinicopathological entity of B-cell origin. However, inconsistent results …

Utilizing the monoclonal antibodies L26 (a new antibody possessing immunoreactivity with
B-lymphocytes in paraffin-embedded tissue), LN1, LN2, and Leu-M1, 44 cases of Hodgkin's …

In the past decade there have been many advances in our understanding of Hodgkin's
disease. Among the most important is the discovery that the Reed–Sternberg cell is a …

The cell lineage and clonality of the presumed neoplastic cells of Hodgkin's disease (HD),
the diagnostic Reed-Sternberg cells and their variants (H/RS cells), have not yet been …

Over the last decade, it has been noted that nodular lymphocytic and/or histiocytic
predominance Hodgkin's disease (NLPHD) has clinical, histological, and …

THE RETROSPECTIVE REPORT from the multicenter European Task Force on Lymphoma
(ETFL) project appearing in this edition of the Journal of Clinical Oncology1 compares the …